top of page

Blincyto: Dosage and Administration

Updated: Apr 7, 2023



Blincyto (blinatumomab) is a medication that is used to treat a certain type of blood cancer called acute lymphoblastic leukemia (ALL). Blincyto is given as an injection into a vein (intravenous infusion) through a needle placed in your arm.


The medication works by helping your body's immune system recognize and attack cancer cells. Blincyto is a type of medication called a bispecific T-cell engager (BiTE) antibody. It works by binding to two different types of cells: CD19, which is found on the surface of cancer cells, and CD3, which is found on the surface of T cells. By binding to both types of cells, Blincyto helps to bring T cells closer to cancer cells, which can lead to the destruction of the cancer cells.


The dosing and administration of Blincyto may vary depending on your individual situation, so it is important to follow your healthcare provider's instructions carefully. Blincyto is typically given in cycles of treatment, with each cycle consisting of 28 days of treatment followed by a break before starting the next cycle.


As with any medication, Blincyto can cause side effects, some of which may be serious. Common side effects may include fever, headache, chills, and low blood cell counts. We are the most dependable suppliers; if you want to buy blincyto injection in India at a low cost, call us at 18008891064, and we will respond as soon as possible and do our best to assist you.

Recent Posts

See All

Buy Blincyto (Blinatumomab 38.5 mcg Injection) Online

Blincyto is a bispecific CD19-directed CD3 T-cell engager approved by the US FDA for the treatment of both adults and children with: B-cell precursor ALL (type of cancer of the blood and bone marrow t

bottom of page